FACTORS INFLUENCING SURVIVAL IN 100 PATIENTS WITH THYROID MALIGNANCY.
D000230:Adenocarcinoma; D000231:Adenocarcinoma, Papillary; D000236:Adenoma; D000293:Adolescent; D002277:Carcinoma; D002294:Carcinoma, Squamous Cell; D002648:Child; D005354:Fibrosarcoma; D005853:Geriatrics; D005870:Giant Cell Tumors; D006042:Goiter; D006801:Humans; D007456:Iodine Isotopes / Q000627:therapeutic use*; D008207:Lymphatic Metastasis; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D009369:Neoplasms / Q000453:epidemiology* / Q000532:radiotherapy*; D010336:Pathology; D011379:Prognosis; D012509:Sarcoma; D013964:Thyroid Neoplasms; D013965:Thyroidectomy
D007456:Iodine Isotopes
ADENOCARCINOMA, PAPILLARY; ADENOMA; ADOLESCENCE; CARCINOMA; CARCINOMA, EPIDERMOID; CHILD; FIBROSARCOMA; GERIATRICS; GIANT CELL TUMORS; GOITER; IODINE ISOTOPES, THERAPEUTIC; LYMPHATIC METASTASIS; NEOPLASM RADIOTHERAPY; NEOPLASM STATISTICS; PATHOLOGY; PROGNOSIS; REVIEW; SARCOMA, RETICULUM CELL; THYROID NEOPLASMS; THYROIDECTOMY